Clinical trial · Observational
Follow-up of Cell Changes in the Cervix
NCT05709730CI-TRIAL-00081478active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to follow up on cell changes detected in the cervical cancer screening program, to investigate whether they are handled with adequate quality.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Cervix | Malignant Cervical Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HPV genotyping | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Women aged 26-80 with atypical glandular cell (AGC) cytology result
- description
- Women in the capital region of Sweden with AGC, a concomitant human papillomavirus (HPV) analysis, and a histopathology.
- interventionNames
- Diagnostic Test: HPV genotyping
Primary outcomes (1)
- measure
- cervical intraepithelial neoplasia 3 (CIN3+)
- timeFrame
- 2014-2018
- description
- Risk for developing CIN3+ or worse depending on HPV type
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 23 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * women with an AGC diagnosis between February 17, 2014 and December 31, 2018 * 23-80 years old * resident of the Stockholm-Gotland region of Sweden Exclusion Criteria: \-
References
Publications (1)
- BACKGROUNDNorman I, Yilmaz E, Hjerpe A, Hortlund M, Elfstrom KM, Dillner J. Atypical glandular cells and development of cervical cancer: Population-based cohort study. Int J Cancer. 2022 Dec 1;151(11):2012-2019. doi: 10.1002/ijc.34242. Epub 2022 Aug 27. PMID 36029205